Two thyroid cancer cell lines, BCPAP and KHM-5M were transfected with siRNA targeting LRRK2, and the knockdown efficiency were confirmed by qPCR and Western blot (Supplementary Fig. 4a, b). This evidence concerns the gene LRRK2 and thyroid cancer.